|
Mr. Kay has more than 25 years of medical devices/biotechnology experience that he brings to the table as Chief Executive Officer of Response Biomedical Corporation. He is a former President, CEO and Director of Quidel Corporation, a leading global company in the discovery, development, manufacturing and marketing of rapid diagnostic solutions at the point-of-care (POC) in infectious diseases and reproductive health. During his tenure he designed and managed a strategy responsible for building and sustaining unprecedented market leadership of rapid influenza testing (from an approximately 2 percent to 49 percent market share). He was also responsible for significantly improving the financial performance of the company during his tenure. Since leaving Quidel in 2004, Mr. Kay served as an executive advisor to the management and boards of several early stage companies, mainly in the San Francisco Bay and San Diego areas. He also served as an executive advisor to one the US's most successful healthcare/life sciences blue chip venture capital funds, Kleiner Perkins Caufield and Byers. | 